N-1,10-phenanthrolin-5-ylacetamide

N-1,10-phenanthrolin-5-ylacetamide Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name N-1,10-phenanthrolin-5-ylacetamide
Generic N-1,10-phenanthrolin-5-ylacetamide
Type
Formula C14H11N3O
Weight Average: 237.2566
Monoisotopic: 237.090211989
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
N-1,10-phenanthrolin-5-ylacetamide
N-1,10-phenanthrolin-5-ylacetamide

Innovators Monograph

You find simplified version here N-1,10-phenanthrolin-5-ylacetamide



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=18719622
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444911
https://www.chemspider.com/Chemical-Structure.18970157.html
https://zinc.docking.org/substances/ZINC000053683165
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/PXX
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE
4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile
(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE
3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile
3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL
(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol
2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid
N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
Upper GI and small bowel series
Breast MRI scan
Lymph node culture
Ureteral retrograde brush biopsy
Bone marrow culture
Thyroid function tests
Sweat Test for Cystic Fibrosis
CMV blood test
Fetal-maternal erythrocyte distribution blood test
Screening and diagnosis for HIV
Spastic colitis
To increase percutaneous drug absorption
Itching of the perianal area
Gestational Diabetes Mellitus (GDM)
Ophthalmia
Hyperuricemia
Untreated with antiretrovirals HIV-1
Non-mestatatic castrate-resistant prostate cancer
Corneal Abrasions
Edema